Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapyRuan F.V. Medrano(Universidade de São Paulo), Bryan E. Strauss(Universidade de São Paulo)Scientific ReportsAugust 10, 202210.1038/s41598-022-17775-yCited by 6SaveCiteExport RISWatch citationsRelated PapersDermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling|BMC Cancer|2015|34